Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment

Annals of Medicine

Volumn 44, Issue 1, 2012, Pages 29-40

  Alisi, Anna ^a   Cianfarani, Stefano ^a,b   Manco, Melania ^a   Agostoni, Carlo ^c   Nobili, Valerio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Adolescents; life style; metabolic syndrome; non alcoholic fatty liver disease

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; FATTY ACID; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LEPTIN; LIPOPOLYSACCHARIDE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RESISTIN; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIET; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; FETUS DEVELOPMENT; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HORMONE RELEASE; HUMAN; INCIDENCE; INNATE IMMUNITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; LIFESTYLE; LIPID STORAGE; LIVER BIOPSY; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUTRITION; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; RISK FACTOR; SEDENTARY LIFESTYLE; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW (TOPIC); ULTRASOUND; URBANIZATION; UTERUS; WAIST CIRCUMFERENCE;

ADOLESCENT; CHILD; FATTY LIVER; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER; METABOLIC SYNDROME X; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 84856301079     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.547869     Document Type: Review

References (137)

1. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366:1059-62. (Pubitemid 41338752)
2. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469-80.
3. International Diabetes Federation, 2010. Available at: http://www.idf.org/idf-worldwide-definition-metabolic-syndrome. Accessed date: 13 October 2010.
4. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents. Lancet. 2007;369:2059-61. (Pubitemid 46935928)
5. International Diabetes Federation, 2010. Available at: http://www.idf.org/node/1405?unode-4A7F23CB-FA35-4471-BB06-0294AD33F2FC. Accessed date: 13 October 2010.
6. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation . 2009;119:628-47.
7. Kiess W, Blüher S, Kapellen T, Körner A. Metabolic syndrome in children and adolescents: prevalence, public health issue, and time for initiative. J Pediatr Gastroenterol Nutr. 2009;49:268-71.
8. Guerrero-Romero F, Aradillas-García C, Simental-Mendia LE, Monreal-Escalante E, de la Cruz Mendoza E, Rodríguez-Moran M. Birth weight, family history of diabetes, and metabolic syndrome in children and adolescents. J Pediatr. 2010;156:719-23, 723.e1.
9. Biro FM, Wien M. Childhood obesity and adult morbidities. Am J Clin Nutr. 2010;91:1499S-1505S.
10. Edmison JM, Kalhan SC, McCullough AJ. Obesity, hepatic metabolism and disease. Nestle Nutr Workshop Ser Pediatr Program. 2009;63:163-72; discussion 172-6, 259-68.
11. Sundaram SS, Zeitler P, Nadeau K. The metabolic syndrome and nonalcoholic fatty liver disease in children. Curr Opin Pediatr. 2009;21:529-35.
12. Alisi A, Manco M, Vania A, Nobili V. Pediatric nonalcoholic fatty liver disease in 2009. J Pediatr. 2009;155:469-74.
13. Alisi A, Locatelli M, Nobili V. Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care. 2010;13: 397-402.
14. Lobstein T, Jackson-Leach R. Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. Int J Pediatr Obes. 2006;1:33-41.
15. Farrell GC. The liver and the waistline: Fifty years of growth. J Gastroenterol Hepatol. 2009;24 Suppl 3:S105-18.
16. Nobili V, Cianfarani S, Agostoni C. Programming, metabolic syndrome, and NAFLD: the challenge of transforming a vicious cycle into a virtuous cycle. J Hepatol. 2010;52:788-90.
17. Nobili V, Alisi A, Panera N, Agostoni C. Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. Pediatr Endocrinol Rev. 2008; 6:241-7.
18. Lambert M, Paradis G, O' L oughlin J, Delvin EE, Hanley JA, Levy E. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord. 2004;28:833-41. (Pubitemid 39005683)
19. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362-74. (Pubitemid 38702847)
20. Rodríguez-Morán M, Salazar-Váz quez B, Violante R, Guerrero-Romero F. Metabolic syndrome among children and adolescents aged 10-18 years. Diabetes Care. 2004;27: 2516-7. (Pubitemid 39281417)
21. Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: Will the real definition please stand up. J Pediatr. 2008;152:160-4.
22. National Institutes of Health. The third report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Bethesda: National Institutes of Health; 2001.
23. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821-7. (Pubitemid 36988016)
24. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494-7. (Pubitemid 39407358)
25. Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among US adolescents, 1999-2000. Diabetes Care. 2004;27:2438-43. (Pubitemid 39281398)
26. Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch Pediatr Adolesc Med. 2009;163:371-7.
27. Hoffman RP. Metabolic syndrome racial differences in adolescents. Curr Diabetes Rev. 2009;5:259-65.
28. Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7:195-203.
29. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2009;50:1282-93.
30. Pietrobattista A, Fruwirth R, Natali G, Monti L, Devito R, Nobili V. Is juvenile liver biopsy unsafe? Putting an end to a common misapprehension. Pediatr Radiol . 2009;39:959-61.
31. Vizzutti F, Arena U, Nobili V, Tarquini R, Trappoliere M, LaffiG, et al. Non-invasive assessment of fibrosis in nonalcoholic fatty liver disease. Ann Hepatol. 2009;8:89-94.
32. Springer F, Machann J, Claussen CD, Schick F, Schwenzer NF. Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol . 2010;16:1560-6.
33. Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology . 2008;48:442-8.
34. Barshop NJ, Francis CS, Schwimmer JB, Lavine JE. Nonalcoholic fatty liver disease as a comorbidity of childhood obesity. Ped Health. 2009;3:271-81.
35. Alisi A, Manco M, Panera N, Nobili V. Association between type two diabetes and non-alcoholic fatty liver disease in youth. Ann Hepatol. 2009;8 Suppl 1:S44-50.
36. Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology . 2006;44:458-65. (Pubitemid 44214885)
37. Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, Rosenthal P, et al. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol . 2010;105:2093-102.
38. Almeda-Valdés P, Cuevas-Ramos D, Aguilar-Salinas CA. Metabolic syndrome and non-alcoholic fatty liver disease. Ann Hepatol. 2009;8(Suppl 1):S18-24.
39. Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Järvinen H, Svegliati-Baroni G. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis . 2010; 42:320-30.
40. Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J, et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care. 2006;29:113-22. (Pubitemid 44033441)
41. Jasik CB, Lustig RH. Adolescent obesity and puberty: the' perfect storm' . Ann N Y Acad Sci. 2008;1135:265-79. (Pubitemid 351862125)
42. Joy T, Lahiry P, Pollex RL, Hegele RA. Genetics of metabolic syndrome. Curr Diab Rep. 2008;8:141-8.
43. Valsamakis G, Kanaka-Gantenbein C, Malamitsi-Puchner A, Mastorakos G. Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome. Ann N Y Acad Sci. 2006;1092:138-47. (Pubitemid 47092333)
44. Funahashi T, Matsuzawa Y. Metabolic syndrome: clinical concept and molecular basis. Ann Med. 2007;39:482-94. (Pubitemid 350035569)
45. Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child. 2005;90:10-14. (Pubitemid 40052245)
46. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607. (Pubitemid 19004941)
47. Chiarelli F, Marcovecchio ML. Insulin resistance and obesity in childhood. Eur J Endocrinol. 2008;159 Suppl 1: S67-74.
48. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-28. (Pubitemid 40523737)
49. Kennedy AJ, Ellacott KL, King VL, Hasty AH. Mouse models of the metabolic syndrome. Dis Model Mech . 2010;3: 156-66.
50. O' S ullivan TA, Lyons-Wall P, Bremner AP, Ambrosini GL, Huang RC, Beilin LJ, et al. Dietary glycaemic carbohydrate in relation to the metabolic syndrome in adolescents: comparison of different metabolic syndrome definitions. Diabet Med . 2010;27:770-8.
51. Aeberli I, Spinas GA, Lehmann R, l' A llemand D, Molinari L, Zimmermann MB. Diet determines features of the metabolic syndrome in 6-to 14-year-old children. Int J Vitam Nutr Res . 2009;79:14-23.
52. Pan Y, Pratt CA. Metabolic syndrome and its association with diet and physical activity in US adolescents. J Am Diet Assoc . 2008;108:276-86.
53. Sookoian S, Pirola CJ. Metabolic syndrome: From the genetics to the pathophysiology. Curr Hypertens Rep . 2010 Oct 19 (Epub ahead of print).
54. Pankow JS, Jacobs DR Jr, Steinberger J, Moran A, Sinaiko AR. Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome. Diabetes Care. 2004;27:775-80. (Pubitemid 38280549)
55. Santoro N, Cirillo G, Amato A, Luongo C, Raimondo P, D' Aniello A, et al. Insulin gene variable number of tandem repeats (Ins Vntr) genotype and metabolic syndrome in childhood obesity. J Clin Endocrinol Metab. 2006;91: 4641-4. (Pubitemid 44833450)
56. Chu NF, Chang JB, Shieh SM. Plasma leptin, fatty acids, and tumor necrosis factor-receptor and insulin resistance in children. Obes Res . 2003;11:532-40.
57. Kör ner A, Kratzsch J, Gausche R, Schaab M, Erbs S, Kiess W. New predictors of the metabolic syndrome in children-role of adipocytokines. Pediatr Res. 2007;61:640-5. (Pubitemid 46800270)
58. Calcaterra V, De Amici M, Klersy C, Torre C, Brizzi V, Scaglia F, et al. Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents. Acta Biomed . 2009;80: 117-23.
59. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol . 2010;314:1-16.
60. T úri S, Friedman A, Bereczki C, Papp F, Kovà c s J, Karg E, et al. Oxidative stress in juvenile essential hypertension. J Hypertens. 2003;21:145-52. (Pubitemid 36143519)
61. Sinaiko A, Steinberger J, Moran A, Prineas RJ, Vessby B, Basu S, et al. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation. 2005;111:1985-91. (Pubitemid 40570219)
62. Kelly AS, Steinberger J, Kaiser DR, Olson TP, Bank AJ, Dengel DR. Oxidative stress and adverse adipokine profile characterize the metabolic syndrome in children. J Cardiometab Syndr. 2006;1:248-52.
63. McCall A, Raj R. Exercise for prevention of obesity and diabetes in children and adolescents. Clin Sports Med. 2009;28:393-421.
64. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008;48 Suppl 1: S104-12.
65. Tilg H, Moschen AR. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab. 2008;19:371-9.
66. Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol. 2009;51:212-23.
67. Cheung O, Sanyal AJ. Abnormalities of lipid metabolism in nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28:351-9.
68. Tessari P, Coracina A, Cosma A, Tiengo A. Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2009;19:291-302.
69. Cusi K. Role of insulin resistance and lipotoxicity in nonalcoholic steatohepatitis. Clin Liver Dis . 2009;13:545-63.
70. Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 2009;48:1-26.
71. Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. Scand J Gastroenterol. 2009;44:6-14.
72. Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond). 2008;32:381-7. (Pubitemid 351271778)
73. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlations of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003;143:500-5. (Pubitemid 37352510)
74. Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L. Molecular mechanisms involved in NAFLD progression. J Mol Med. 2009;87:679-95.
75. Duvnjak M, Leroti I, Barsi N, Tomasi V, Virovi Juki L, Velagi V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol. 2007; 13:4539-50. (Pubitemid 47455230)
76. Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology . 2010;52:774-88.
77. Kamada Y, Takehara T, Hayashi N. Adipocytokines and liver disease. J Gastroenterol. 2008;43:811-22.
78. Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med. 2009;9:299-314.
79. L outhan MV, Barve S, McClain CJ, Joshi-Barve S. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. J Pediatr. 2005;147:835-8. (Pubitemid 41774843)
80. Nobili V, Manco M, Ciampalini P, Diciommo V, Devito R, Piemonte F, et al. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol. 2006;155:735-43. (Pubitemid 44857498)
81. Alisi A, Manco M, Devito R, Piemonte F, Nobili V. Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2010;50:645-9.
82. Wilfred de Alwis NM, Day CP. Genes and nonalcoholic fatty liver disease. Curr Diab Rep. 2008;8:156-63.
83. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388-93. (Pubitemid 46393782)
84. Day CP. Genetic and environmental susceptibility to nonalcoholic fatty liver disease. Dig Dis . 2010;28:255-60.
85. Duvnjak M, Barsi N, Tomasi V, Leroti I. Genetic polymorphisms in non-alcoholic fatty liver disease: clues to pathogenesis and disease progression. World J Gastroenterol. 2009;15:6023-7.
86. Sookoian S, García SI, Gianotti TF, Dieuzeide G, Gonz ález CD, Pirola CJ. The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with hypertension in adolescents harboring the metabolic syndrome. Am J Hypertens. 2005;18:1271-5. (Pubitemid 41400193)
87. Sookoian SC, González C, Pirola CJ. Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome. Obes Res. 2005;13:2122-31.
88. Zák A, JáchymováM, TvrzickáE, Vecka M, DuffkováL, Zeman M, et al. The influence of polymorphism of-493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress. J Nutr Biochem . 2008;19: 634-41.
89. Vasseur F, Meyre D, Froguel P. Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies. Expert Rev Mol Med. 2006;8:1-12. (Pubitemid 44782612)
90. Ferguson JF, Phillips CM, Tierney AC, Pérez-Martínez P, Defoort C, Helal O, et al. Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am J Clin Nutr. 2010;91:794-801.
91. Sookoian S, García SI, Porto PI, Dieuzeide G, González CD, Pirola CJ. Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents. J Mol Endocrinol. 2005;35:373-80. (Pubitemid 41556183)
92. Vimaleswaran KS, Radha V, Deepa R, Mohan V. Absence of association of metabolic syndrome with PPARGC1A, PPARG and UCP1 gene polymorphisms in Asian Indians. Metab Syndr Relat Disord. 2007;5:153-62. (Pubitemid 46954300)
93. Robitaille J, Brouillette C, Houde A, Lemieux S, Pérusse L, Tchernof A, et al. Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome. J Hum Genet . 2004;49:482-9. (Pubitemid 39314367)
94. Phillips CM, Goumidi L, Bertrais S, Field MR, Ordovas JM, Cupples LA, et al. Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults. J Nutr. 2010;140:238-44.
95. Stanc ák ováA, BaldaufováL, JavorskýM, Kozár ováM, Salagovic J, Tk ác I. Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome. Physiol Res. 2006;55:483-90. (Pubitemid 44611193)
96. Zhou YJ, Li YY, Nie YQ, Yang H, Zhan Q, Huang J, et al. Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people. J Gastroenterol Hepatol. 2010;25:772-7.
97. Chien KL, Hsu HC, Chen YC, Su TC, Lee YT, Chen MF. Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis. Transl Res . 2009;154:133-41.
98. Johansson LE, Johansson LM, Danielsson P, Norgren S, Johansson S, Marcus C, et al. Genetic variance in the adiponutrin gene family and childhood obesity. PLoS One. 2009;4:e5327.
99. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461-5.
100. Hoekstra M, Li Z, Kruijt JK, Eck MV, Berkel TJ, Kuiper J. The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status. J Hepatol. 2010;52:244-51.
101. Wilson PA, Gardner SD, Lambie NM, Commans SA, Crowther DJ. Characterization of the human patatin-like phospholipase family. J Lipid Res. 2006;47:1940-9. (Pubitemid 44401981)
102. Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, et al. Homozygosity for the PNPLA3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51:1209-17.
103. Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, et al. I148M patatin-like phospholipase domaincontaining 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology. 2010;52:1274-80.
104. Hales C, Barker D, Clark P, Cox L, Fall C, Osmond C, et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991;303:1019-22.
105. Geremia C, Cianfarani S. Insulin sensitivity in children born small for gestational age (SGA). Rev Diabet Stud. 2004;1: 58-65.
106. Lévy-Marchal C, Czernichow P. Small for gestational age and the metabolic syndrome: which mechanism is suggested by epidemiological and clinical studies? Horm Res. 2006;65 Suppl 3:123-30. (Pubitemid 44689444)
107. Fowden A, Giussani D, Forhead A. Intrauterine programming of physiological systems: causes and consequences. Physiology (Bethesda). 2006;21:29-37. (Pubitemid 43752515)
108. Lucas A. Programming by early nutrition in man. Ciba Found Symp. 1991;156:38-50.
109. Godfrey K.M., Lillycrop K.A., Burdge G.C., Gluckman P.D., Hanson M.A. Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease, Pediatric Research, 2007, 61, 5R-10R (Pubitemid 46653061)
110. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull. 2001;60:5-20. (Pubitemid 34123501)
111. Nair L, Nair MK, Chacko DS. Markers of fetal onset adult diseases. Indian Pediatr . 2009;46:48-54.
112. Ross MG, Beall MH. Adult sequelae of intrauterine growth restriction. Semin Perinatol. 2008;32:213-8. (Pubitemid 351636319)
113. Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet. 1999; 353:1789-92. (Pubitemid 29240389)
114. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 1998;19: 268-70. (Pubitemid 28309340)
115. Gluckman P, Hanson M, Buklijas T, Low F, Beedle A. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat Rev Endocrinol. 2009;5:401-8.
116. Goyal R, Goyal D, Leitzke A, Gheorghe C, Longo L. Brain renin-angiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy. Reprod Sci. 2010;17:227-38.
117. Pinney S, Simmons R. Epigenetic mechanisms in the development of type 2 diabetes. Trends Endocrinol Metab. 2010;21:223-9.
118. Heijmans B, Tobi E, Stein A, Putter H, Blauw G, Susser E, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA. 2008;105:17046-9.
119. Eriksson J, Osmond C, Kajantie E, Forsén T, Barker D. Patterns of growth among children who later develop type 2 diabetes or its risk factors. Diabetologia. 2006;49:2853-8. (Pubitemid 44730287)
120. Barker D, Hales C, Fall C, Osmond C, Phipps K, Clark P. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36:62-7. (Pubitemid 23018337)
121. Eriksson J, Forsén T, Tuomilehto J, Jaddoe V, Osmond C, Barker D. Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia. 2002;45:342-8. (Pubitemid 34267356)
122. Claris O, Beltrand J, Levy-Marchal C. Consequences of intrauterine growth and early neonatal catch-up growth. Semin Perinatol. 2010;34:207-10.
123. Fagerberg B, Bondjers L, Nilsson P. Low birth weight in combination with catch-up growth predicts the occurrence of the metabolic syndrome in men at late middle age: the Atherosclerosis and Insulin Resistance study. J Intern Med. 2004;256:254-9. (Pubitemid 39222995)
124. Bhargava S, Sachdev H, Fall C, Osmond C, Lakshmy R, Barker D, et al. Relation of serial changes in childhood bodymass index to impaired glucose tolerance in young adulthood. N Engl J Med. 2004;350:865-75. (Pubitemid 38252534)
125. Ravelli G, Stein Z, Susser M. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med. 1976;295:349-53.
126. Ravelli A, van der Meulen J, Michels R, Osmond C, Barker D, Hales C, et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet. 1998;351:173-7. (Pubitemid 28037007)
127. Ravelli A, van Der Meulen J, Osmond C, Barker D, Bleker O. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am J Clin Nutr. 1999;70:811-6. (Pubitemid 29512905)
128. Roseboom T, van der Meulen J, Ravelli A, van Montfrans G, Osmond C, Barker D, et al. Blood pressure in adults after prenatal exposure to famine. J Hypertens. 1999;17:325-30. (Pubitemid 29116639)
129. Gluckman P, Hanson M. Developmental and epigenetic pathways to obesity: an evolutionary-developmental perspective. Int J Obes (Lond). 2008;32 Suppl 7:S62-71.
130. Kirk S, Samuelsson A, Argenton M, Dhonye H, Kalamatianos T, Poston L, et al. Maternal obesity induced by diet in rats permanently influences central processes regulating food intake in offspring. PLoS One. 2009;4:e5870.
131. Baird J, Fisher D, Lucas P, Kleijnen J, Roberts H, Law C. Being big or growing fast: systematic review of size and growth in infancy and later obesity. BMJ. 2005;331:929.
132. Nobili V, Marcellini M, Marchesini G, Vanni E, Manco M, Villani A, et al. Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care. 2007;30:2638-40. (Pubitemid 47547810)
133. Nobili V, Bedogni G, Alisi A, Pietrobattista A, Alterio A, Tiribelli C, et al. A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease. Arch Dis Child. 2009;94:801-5.
134. Koletzko B, von Kries R, Closa R, Monasterolo RC, Escribano J, Subias JE, et al. Can infant feeding choices modulate later obesity risk? Am J Clin Nutr. 2009;89:1502S-8S.
135. Schack-Nielsen L, Sorensen TI, Mortensen EL, Michaelsen KF. Late introduction of complementary feeding, rather than duration of breastfeeding, may protect against adult overweight. Am J Clin Nutr. 2010;91:619-27.
136. Bartok CJ, Ventura AK. Mechanisms underlying the association between breastfeeding and obesity. Int J Pediatr Obes. 2009;4:196-204.
137. Brambilla P, Lissau I, Flodmark CE, Moreno LA, Widhalm K, Wabitsch M, et al. Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome. Int J Obes. 2007;31:591-600. (Pubitemid 46482362)